gh2616
Small moleculeexperimental
Clinical trial activity
2 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 20, 2024 (NCT06329206)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Kinesin-like protein KIF18AINHIBITOR
KIF18A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07260513 | Phase 1 | Mar 27, 2025 | Chinese Academy of Medical Sciences, Fudan University, GCP-Service International Ltd. & Co. KG, Government of China, Suzhou Genhouse Bio Co., Ltd. |
| NCT06329206 | Phase 1 | Mar 20, 2024 | Chinese Academy of Medical Sciences, Henan Medical University, Suzhou Genhouse Bio Co., Ltd., Wuhan University, Zhengzhou University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 0 | 1 | 2024 |
| Suzhou Genhouse Bio Co., Ltd. | For profit | 2 | 2 | 1 | 2024 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| GCP-Service International Ltd. & Co. KG | For profit | 1 | 0 | 1 | 2025 |
| Government of China | Government | 1 | 0 | 1 | 2025 |
| Henan Medical University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Wuhan University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Zhengzhou University | Academic/Hospital | 1 | 0 | 1 | 2024 |
8 organizations
Page 1 / 1